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Abstract
Background: Marjolin’s ulcer is a rare but highly aggressive squamous cell cancer that is most often associated
with chronic burn wounds. Although many individual case reports exist, no comprehensive evaluation of Marjolin’s
ulcer patients has been conducted in our setting. This study was conducted to describe the clinicopathological
presentation and treatment outcome of this condition in our local setting and to identify predictors of outcome.
Methods: This was a retrospective study of histologically confirmed cases of Marjolin’s ulcer seen at Bugando
Medical Centre over a period of 10-years between January 2001 and December 2010. Data were retrieved from
patients’ files and analyzed using SPSS computer software version 15.0
Results: A total of 56 patients were studied. Male to female ratio was 2.1:1. Burn scars (89.3%) were the most
common causative lesions of Marjolin’s ulcer. The mean latent period between original injury and diagnosis of
Marjolin’s ulcer was 11.34 ± 6.14 years. Only 12.0% of the reported cases were grafted at the time of injury (P <
0.00). Most patients (48.2%) presented between one and five years of onset of illness. The lower limb (42.9%) was
the most frequent site for Marjolin’s ulcers. The median tumor size at presentation was 8 cm and the vast majority
of patients (85.7%) presented with large tumors of ≥ 5 cm in diameter. Lymph node metastasis at the time of
diagnosis was recorded in 32.1% of cases and distant metastasis accounted for 26.9% of cases. Squamous cell
carcinoma (91.1%) was the most common histopathological type. Wide local excision was the most common
surgical procedure performed in 80.8% of cases. Post-operative complication rate was 32.1% of which surgical site
infection was the most common complication in 38.9% of patients. Local recurrence was noted in 33.3% of cases
who were treated surgically. The mean length of hospital stay for in-patients was 7.9 ± 2.3 days. Mortality rate was
7.1%. According to multivariate logistic regression analysis, stage and grade of the tumor and presence of local
recurrence were the main predictors of death (P < 0.001).
Conclusion: Marjolin’s ulcers are not rare in our environment and commonly occur in burn scars that were not
skin grafted and were left to heal secondarily. A high index of suspicion is required in the management of chronic
non-healing ulcers and all suspected lesions should be biopsed. Early recognition and aggressive treatment of
Marjolin’s ulcers and close follow-up are urgently needed to improve outcomes in our environment.
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Marjolin’s ulcer is a rare and often aggressive cutaneous
malignancy that arises in previously traumatized or
chronically inflamed skin, particularly after burns [1].
Marjolin’s ulcers have a 1% to 2% incidence in all burn
scars but can also develop from previously traumatized
and scarred tissue of other etiologies such as chronic
sinuses of osteomyelitis, post-traumatic wounds, pressure
sores and chronic fistulae and have been reported to
arise in the genitalia as a complication of Fournier’s gang-
rene [2]. The term “Marjolin’su l c e r ” was named after
French surgeon, Jean Nicolas Marjolin, who first
described the condition in 1828 [1-3]. But it was Dupuyt-
ren who noted it was a malignancy [4]. In 1923, DaCosta
first coined the expression “Marjolin’s ulcer” to describe
malignant tumors forming over burn injuries [5].
The exact mechanism of malignant transformation of
Marjolin’s ulcer remains unclear and controversial [6-8].
Several theories including the toxin, chronic irritation,
traumatic epithelial elementsi m p l a n t a t i o n ,h e r e d i t y ,
immunologic privileged site, co-carcinogen, ultraviolet
rays, initiation and promotion and environmental and
genetic interaction theories have been reported to
explain the malignant transformation [9].
T h el a t e n c yp e r i o df r o mt h et i m eo fi n j u r yt ot h e
onset of malignant transformation averages 36 years
[10]. However, early arising Marjolin’s ulcers have been
described in the literature [8,11]. Studies from western
countries have shown that the average age at diagnosis
is in the fifth decade of life with a range of 18-84 years,
and men are three times more frequently affected than
women [11]. In Sub-Saharan Africa, Marjolin’su l c e r
appears to be affecting younger patients and the transi-
tion time is getting shorter over the years [12].
Most lesions of Marjolin’s ulcer occur on the extremi-
ties (60%), with ulcers on the head and face occurring
less frequently (30%) and the lowest frequency (10%) on
the trunk [4]. Marjolin’su l c e r si nu n u s u a ls i t e ss u c ha s
the genitalia as a complication of Fournier’s gangrene
[13] and breast skin developing in a postburn scar [14]
have also been reported.
Marjolin’s ulcers are very aggressive tumors that
necessitate a well thought out treatment plan to opti-
mize care and assure patient survival [14]. Early diagno-
sis and prompt surgical intervention is mandatory in
Marjolin’s ulcers as they may invade vital structures.
However, in developing countries like Tanzania, most
patients with these lesions are treated as chronic ulcers
or infections and present late to hospitals, leading to a
delayed diagnosis and resulting in the need for more
extensive surgery and an increased risk of metastasis.
Marjolin’s ulcers presents histopathologically as squa-
mous cell carcinoma in 75% to 96% of cases [15]. Other
neoplasms, such as basal cell carcinomas, melanoma,
osteogenic sarcoma, fibrosarcoma, and liposarcoma,
have also been reported [8,16].
In spite of being a surface malignancy and more
amenable not only to early detection, but also to a
potential cure, the outcome of treatment in most devel-
oping countries including Tanzania has been poor
because the majority of these patients present late to the
hospital with advanced stage. This is partly due to pau-
city of local data regarding this condition and lack of
community awareness on the importance of early
reporting to hospital for early diagnosis and treatment.
This study was conducted to evaluate the clinicopatho-
logical presentation and treatment outcome of this con-
dition in our local setting and to identify predictors of
outcome.
Methods
Study design and setting
This was a retrospective study of histologically con-
firmed cases of Marjolin’s ulcer seen at the department
of Surgery of Bugando Medical Centre (BMC) over a
period of 10-years between January 2001 and December
2010. BMC is a consultant, tertiary care and teaching
hospital for the Catholic University of Health and allied
Sciences-Bugando (CUHAS-Bugando) and has a bed
capacity of 1000.
Study population
The subjects of this study included all patients who pre-
sented to BMC with histologically confirmed Marjolin’s
ulcers during the period studied. Patients with incom-
plete data were excluded from the study. The details of
patients were retrieved from patients’ files kept in the
Medical record department, the surgical wards, operat-
ing theatre and histopathology laboratory. Information
retrieved included demographic data, causative previous
lesions, latency period, duration of illness, anatomical
site, radiological investigations, histological types, treat-
ment modalities, management complications, length of
hospital stay and mortality.
Statistical analysis
Data collected were analyzed using SPSS computer soft-
ware version 15.0 (SPSS, Inc, Chicago, IL). Data was
summarized in form of proportions and frequency tables
for categorical variables. Continuous variables were
summarized using mean, median, mode and standard
deviation. Chi -square (c
2-test) was used to test for sig-
nificance of associations between the predictor and out-
come variables in the categorical variables. Student t-
test was used to test for significance of associations
between the predictor and outcome variables in the
Chalya et al. World Journal of Surgical Oncology 2012, 10:38
http://www.wjso.com/content/10/1/38
Page 2 of 8continuous variables. Significance was defined as a p-
value of < 0.05. Multivariate logistic regression analysis
was used to determine predictor variables that are asso-
ciated with outcome.
Ethical consideration
Ethical approval to conduct the study was sought from
the CUHAS-Bugando/BMC joint institutional ethic




During the period under study, a total of 56 patients
were studied. Males were 38 (67.9%) and females were
18 (32.1%) with a male to female ratio of 2.1:1. Their
mean and median ages were 38.2 ± 24.2 years and 37
years respectively (range 12-78 years). The modal age
group was 31-40 years. The majority of patients, 39
(69.6%) were younger than 40 years. The vast majority
of patients, 49 (87.5%) came from the rural areas located
ac o n s i d e r a b l ed i s t a n c ef r o mM w a n z aC i t ya n dm o s to f
them, 51 (91.1%) had either primary or no formal
education.
Causative previous lesions
Burn scars were the most common causative lesions of
Marjolin’s ulcer, representing 89.3% of cases. The mean
latent period between original injury and development
of Marjolin’s ulcer was 11.34 ± 6.14 years (range from
five months to 48 years). Skin grafting of the previous
causative lesions was reported in only six (10.7%)
patients and the rest of the lesions healed by either
delayed primary or secondary intention.
Clinical presentation
The duration of illness (the period from development of
Marjolin’s ulcer and presentation to health facility) ran-
ged from 1 month to 8 years with a median of 4 years
and the majority of patients (48.2%) presented between
one and five years of onset of illness. The reasons for
late presentation are shown in Table 1. Forty-six (82.1%)
patients had undergone some form of intervention in
peripheral dispensaries and hospitals before been
referred, with dressing and inadequate surgical resection
being the most common intervention.
The lower limb was the most frequent site for Marjo-
lin’s ulcers accounting for 42.9% of patients. The major-
ity of patients presented with increasing pain (92.9%)
and foul smelling pus discharge (89.3%) and most of
them (51.8%) had exophytic proliferative ulcers. The
median tumor size at presentation was 8 cm (range 2 to
16 cm) and the vast majority of patients (85.7%) pre-
sented with large tumors of ≥ 2c mi nd i a m e t e r .M o s t
patients (44.6%) had no evidence of metastases. Lymph
node metastasis at the time of diagnosis was recorded in
32.1% of cases. Distant metastasis accounted for 26.9%
of cases and occurred mostly in the lungs, liver, bone
and brain in 6 (40.0%), 5(33.3%), 2 (13.3%) and 2
(13.3%) patients respectively (Table 1).
Investigations
A total of 70 radiological investigations were performed
to rule out distant metastasis; of these, plain radiographs
were the most frequent radiological investigation per-
formed accounting for 64.3% of all the radiological
investigations (Table 2). Table 3 shows histopathological
findings of various Marjolin’s ulcers. Squamous cell car-
cinoma was the most common histopathological type
accounting for 91.1% of all Marjolin’s ulcers. The major-
ity of these tumors (Marjolin’s ulcers) were moderate
differentiation in 41.1%. The depth of dermal invasion
and vertical tumor thickness is shown in Table 3.
Treatment modalities
In the present study, fifty-two (92.9%) patients under-
went surgical treatment. Of these, wide local excision
was the most common surgical procedure performed in
80.8% of cases (Table 4).
Clinical Outcome
Post-operative complications were recorded in 18
(32.1%) patients. Of these, surgical site infection was the
most common post-operative complication accounting
for 38.9% of cases (Table 5). The majority of patients,
51 (91.1%) required hospitalization for their treatment
and the remaining 5(8.9%) were treated as outpatients.
The length of hospital stay for in-patients ranged from
6t o2 1d a y s( m e a n7 . 9±2 . 3d a y s ) .F o u rp a t i e n t sd i e d
in hospital giving a mortality rate of 7.1%. According to
multivariate logistic regression analysis, stage and grade
of the tumor, presence of metastases and presence of
local recurrence were the main predictors of death (P <
0.001). Local recurrence was noted in 33.3% of cases
who had surgical treatment. All cases of local recur-
rence of ulcers occurred from 6 months to 1 year
(mean 8.3 ± 3.4 months) after definitive treatment.
Tumor size, histological grade of the tumor, stage of
the tumor and presence of metastasis at the time of
diagnosis were the main predictors of local recurrence
(P < 0.001).
Discussion
Marjolin’su l c e ri sd e f i n e da sat u m o ra r i s i n gf r o ma
chronic wound, scar or chronic inflammation [1,2]. Jean
Nicholas Marjolin first described the malignant transfor-
mation of cutaneous scars in 1828 [1-3]. Since then, sev-
eral reports of post-burn scar ulcers have been reported
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make up 1.2% of all skin cancers [7,17].
In this review, the mean age of patients was 38.2 years
which is lower than the age reported in western coun-
tries [11,18,19]. Current studies in Africa have reported
that the mean age of patients with Marjolin’su l c e r si s
lowering and appears to be affecting younger patients
over the years [12,20]. It also appears that the transition
time is getting shorter [20]. Marjolin’s ulcers in general,
develop in younger patients amongst sub-Saharan
patients than those reported from other regions [12];
therefore, patients presenting with chronic ulcers should
be investigated during the initial evaluation for this pos-
sibility. Further research is needed in our region to
explain this observation.
T h et w o - f o l di n c r e a s ei nt h en u m b e ro fm a l e sw i t h
Marjolin’s ulcers compared to females in the present
study is similar to what was reported in other studies
[7,21,22]. Male preponderance in the present study may
be due to their increased susceptibility to trauma which,
if poorly managed, these lesions have been reported to
undergo malignant transformation.
Marjolin’s ulcer is a malignant change in a long-stand-
ing ulcer and/or scar tissue [22,23]. In agreement with
Table 1 Clinical presentation
Variables Responses Frequency Percentage
Previous lesions Burn scars 50 89.3
Penile human bite scar 1 1.8
Pressure sores 1 1.8
Chronic non healing ulcer 1 1.8
Chronic osteomyelitis 1 1.8
Diabetic foot ulcer 1 1.8
Fournier’s gangrene 1 1.8
Duration of illness (years) < 1 13 23.2
1-5 27 48.2
> 5 16 28.6
Reason for late presentation Financial problem 34 60.7
Treated at peripheral hospitals 32 57.1
Treated by traditional healers 31 55.4
Lack of money for transport 31 55.4
Self medication at home 12 21.4
No reasons documented 12 21.4
Site of the lesion Lower limb 24 42.9
Head & neck 13 23.2
Upper limb 12 21.4
Trunk 4 7.1
Genitalia 2 3.6
Symptoms Increasing pain 52 92.9
Foul smelling pus discharge 50 89.3
Haemorrhage 36 64.3
Increasing discharge 35 62.5
Increasing tumor size 30 53.6
Tumor type Exophylic 27 48.2
Infiltrative 29 51.8
Tumor size Less than 5 cm diameter 8 14.3
5 cm or more diameter 48 85.7
Metastasis at the time of diagnosis Lymph node metastasis 18 26.9
Distant metastasis 15 32.1
No evidence of metastasis 25 44.6
Table 2 Radiological investigations (N = 70)
Radiological study Frequency Percentage
Plain radiographs 45 64.3
Long bone x-rays 28 62.2
Chest x-rays 18 40.0
Skull x-rays 12 26.7
Abdominal ultrasound 16 22.9
Computed Tomography (CT) scan brain 9 12.9
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posing lesion of Marjolin’s ulcers in the present study
was post burn scars. Marjolin ulcers generally occur in
regions of previous deep burn that healed slowly with-
out skin grafting [10]. This observation is reflected in
our study where only 12.0% of patients reported to have
skin grafting for their previous causative lesions. Burn
scar carcinoma has a propensity for the extremities, spe-
cifically to flexion creases of the extremities, where
blood supply is decreased and vulnerability to trauma is
increased [23]. Marjolin’s ulcers have also been reported
following other traumatic injuries, leg ulceration,
chronic sinuses of osteomyelitis, pressure sores, and dis-
coid lupus erythematosus [24].They have also been
documented in the genitalia as a complication of Four-
nier’s gangrene [13]. Interestingly, one patient in our
study was a rare case of a 33 year-old patient who pre-
sented with an early appearance of Marjolin’s ulcer
developing in a penile human bite scar seven months
after the initial injury.
The precise mechanism by which chronic ulcers
(wounds) develop malignancy is not known and many
theories have been postulated [9]. Early theories sug-
gested that cellular mutations as a result of inflamma-
tory related substances release by damaged, ischemic
and nutritionally deficient tissues are responsible for
neoplastic change [4]. Neuman et al [25] proposed that
traumatic displacement of living epithelial tissue into
dermis may cause a foreign body response and lead to a
deranged regenerative process, resulting in carcinoma-
tous change. More recently, a theory of immunologic
isolation has been suggested, whereby lymphatic channel
obliteration at the site of injury decreases the delivery of
antigen or specifically stimulated small lymphocytes to
the regional lymphocytes from that site. This renders
the site ‘immulogically unprivileged’, allowing the devel-
opment of antigenically foreign tumor cells to go
unchecked. Such cells may initially arise by spontaneous
mutation or develop under the influence of viral or che-
mical carcinogens. Tumor antigen recognition may then
be delayed long enough for tumors to reach ‘critical
size’, when immune mechanisms are no longer sufficient
to prevent continued neoplastic progression [26]. It has
also been suggested that patients with an inherent
immune deficiency are at higher risk for developing
malignant ulcers [27]. Some authors have also postu-
lated that with chronic irritation and repeated damage
of the ulcer, there is continuous mitotic activity as the
epidermal cells attempt to resurface the open defect.
This cycle of damage, irritation, and repair can lead to a
malignant transformation [28]. More recent theories
have included genetic postulations involving human leu-
kocyte antigen (HLA) DR4 and mutations in the p53
and/or Fas genes [29-32].
Two variants of Marjolin’s ulcer have been described;
an acute form, in which the cancer occurs within one
year of the injury and a chronic form in which malig-
nant changes are more than one year from the date of
injury. The chronic form is more frequent and malig-
nancy tends to develop slowly, with an average latency
period of 36 years [21,33]. The younger the patient at
the time of injury, the longer the interval for malignant
change, while the older the patient at the time of burn-
ing, the longer the lag period. The results of this study
Table 3 Histopathological results (N = 56)






Basal cell carcinoma 2 3.6
Osteogenic sarcoma 1 1.8
Fibrosarcoma 1 1.8
Melanoma 1 1.8













Not documented 16 28.6
Vertical tumor
thickness
Less than 4 mm thick 9 16.1
4 mm thick or more 35 62.5
Not documented 12 21.4
Table 4 Type of surgical procedures performed (N = 52)
Type of surgical procedure Frequency Percentage
Wide local excision 42 80.8
With skin grafting 36 85.7
With flap 6 14.3
Limb amputation 6 11.5
Minor 2 33.3
Major 4 66.7
Lymph node dissection 4 7.7
Table 5 Postoperative complications (N = 18)
Postoperative complications Frequency Percentage
Surgical site infection 7 38.9
Local recurrence 6 33.3
Loss of skin grafting 2 11.1
Loss of flaps 1 5.5
Stump dehiscence 1 5.5
Re-amputation 1 5.5
Chalya et al. World Journal of Surgical Oncology 2012, 10:38
http://www.wjso.com/content/10/1/38
Page 5 of 8showed an average latency period of 11 years which is
lower than the latency period reported in most western
studies [9,22]. It has been observed that the latency per-
iod is inversely proportional to the patients’ age. The
reason for this phenomenon is unknown.
In keeping with other studies [4,18,21,24,34,35], the
lower limb was the most frequent site for Marjolin’s
ulcers. The anatomical locations reported by Arons [36],
Lawrence [37], and Novick [38] show that average distri-
bution of Marjolin ulcers is 40% in the lower extremity,
30% in the head and face, 20% in the upper extremity,
and 10% in the trunk area. The reason for this anatomi-
cal site predilection is not well understood.
Marjolin’s ulcers are commonly mistaken for an
infected ulceration occurring at the scar tissue sites and
may often be overlooked. Changes such as the appear-
ance of flat, non-healing ulcers enlarging in circumfer-
ence with elevated and indurated borders, foul-smelling,
painful with exudates and bloody drainage suggest a
malignant transformation [39,40]. As in other studies
[8,9,22,39,40], the majority of our patients in the present
study presented with increasing pain, foul smelling pus
discharge, increasing tumor size and most of them had
exophytic proliferative ulcers. It is therefore recom-
mended that all chronic ulcers should be thoroughly
investigated at presentation, to avoid labeling malignan-
cies ‘chronic ulcers’, leading to delay in appropriate
treatment. All patients presenting with chronic ulcers
should undergo multiple biopsies, to help confirm the
neoplasmatic conversion and to avoid missing malignant
ulcers.
Macroscopically, Marjolin’s ulcers have been reported
to exist in two forms which are of prognostic impor-
tance1) Exophytic form characterized by prolonged and
relatively benign course and low probability of distant
metastasis 2) Infiltrative form characterized by rapid for-
mation of ulceration and worse prognosis and high
probability of metastatic spread [22]. Infiltrative Marjo-
lin’s ulcers was the most common form in the present
study accounting for 51.8% of cases and this may be
responsible for the high rate of metastatic spread in our
study.
Marjolin’s ulcers have been reported to have an
aggressive course and a much greater tendency to
metastasize than other types of skin cancer, which
makes early diagnosis imperative. Metastasis to the
brain, liver, lung, kidney, and distant lymph nodes has
been commonly reported [8,21,34,35,41]. In the present
study, 32.1% of patients had lymph node metastasis at
the time of diagnosis and 26.9% of cases had distant
metastasis to the lungs, liver, bone and brain, the rate
which is higher than that reported in other studies
[34,35]. High lymph node and distant metastasis in our
study is due to the fact that most patients in the present
study present late when the disease is already in
advanced stages. In developing countries like ours, espe-
cially in rural areas with poor living conditions most
patients are already in advanced stages of disease at the
time of diagnosis of Marjolin’s ulcer, which has been
proven both in the present study and in literature
[42,43]. In the present study, more than 80% of patients
presented late with large tumor > 2 cm in diameter.
Late presentation is common in most developing coun-
tries as a result of poverty, ignorance, and poor referral
systems in a relatively expensive health care system
devoid of meaningful health insurance [12]. Financial
problem and delayed referral to tertiary health care facil-
ity were the most common reasons for late presentation
in the present study. Health education is highly needed
to discourage patients with cutaneous ulcers from pre-
senting late to hospital when the disease is in its
advanced stage. Early adequate treatment of all ulcers
and scars will certainly reduce the incidence of Marjo-
lin’s ulcer in our setting.
The commonest histopathological type of carcinoma
arising from Marjolin’s ulcer is squamous cell carci-
noma, followed by basal cell carcinoma as the second
commonest carcinoma [7,8,10,16,16,18,22,23]. This find-
ing is in agreement with the present study in which
more than 90% of Marjolin’su l c e r sw e r es q u a m o u sc e l l
carcinoma. Other reported neoplasms are malignant
melanoma, osteogenic sarcoma, fibrosarcoma and lipo-
sarcoma [8,16].
The treatment of Marjolin’s ulcers requires multidisci-
plinary approach. Treatment modalities of Marjolin’s
ulcers include wide local excision, block dissection of
the regional nodes, amputation in advanced lesions of
limbs, radiotherapy and chemotherapy given either as
neo or adjuvant therapy [10]. Wide local excision (surgi-
cal margin of at least 2 cm), together with skin grafting
primarily or primarily delayed, is usually considered
appropriate in the treatment of Marjolin’s ulcers [10,40].
Adequate surgical resection is most important to pre-
vent local recurrence and a margin of 2-5 cm has been
advocated [12,40]. Frozen sections have been reported
to be used for intraoperative diagnosis and evaluation of
surgical excision safety margins [17]. However, like in
most developing countries, frozen sections are not per-
formed in our centre partly because of few available
pathologists and lack of facilities for performing frozen
sections.
Amputation is indicated when wide local excision is
not possible due to deep invasion, bone or joint involve-
ment, infection, or hemorrhage, or when excision would
cause major functional disability. Regional lymph node
dissection is indicated when nodes are clinically palpable
with an exception for malignant melanoma, where the
sentinel lymph node biopsy should be performed
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Sentinel lymph node biopsy has been shown to give as
high yield as 83% [40,44] and is recommended to detect
occult nodal involvement. However, sentinel lymph
node biopsy was not performed in the present study due
to its unavailability in our centre. In agreement with
other studies [10,40], wide local excision with either
skin grafting or flap coverage, was the most frequent
surgical procedure performed in the present study. Limb
amputation and lymph node dissection were performed
in 11.5% and 7.7% of cases. Radiotherapy and che-
motherapy (in the form of four courses of (Methotrex-
ate, Bleomycin and Cisplatinum) is indicated in patients
with poor prognostic factors or distant metastasis
[24,36]. In our study, patients who had inoperable
tumor and those who had recurrences were referred to
Oncological centre for possible palliative radiotherapy/
chemotherapy.
Most series indicate that the incidence of recurrence is
in the range of 20% to 50% [16,24]. Most recurrences
are regional, but metastases to the brain, liver, lung, kid-
ney, and distant lymph nodes have been reported [24].
In the present study, local recurrence was recorded in
33.3% of cases which is higher rate than that is reported
by other authors [8,21,34,35,41]. High recurrence rate in
our study is attributed to delayed presentation and diag-
nosis and this confirmed the highly metastatic potential
of Marjolin’s ulcer among skin malignancies.
Recurrence and fatality rates are higher due to the
aggressive nature of this tumor [28,33].
Our overall mortality rate in the present study was
7.1% that is relatively lowert h a nt h a tr e p o r t e di no t h e r
studies [35,44]. In the present study, mortality rate was
significantly high in patients with high stage and grade of
the tumor and those who had metastases and local recur-
rences reflecting the aggressive nature of this tumor.
The prognosis in Marjolin’s ulcers depends on various
factors like age of the patient, size, grade and stage of
the tumor, presence of metastases, the adequacy of sur-
gery and presence of local recurrence. In the present
study, stage and grade of the tumor, presence of metas-
tases and presence of local recurrence were the main
predictors of death. Appropriate Marjolin’s ulcer patient
prognostication is of paramount important in clinical
decision making, especially the utilization of resources
in poor income countries.
Conclusion
Marjolin’s ulcers are not uncommon in our setting and
commonly occur in burn scars that were not skin
grafted and were left to heal secondarily. They have a
shorter latent period and commonly occurred in
younger male patients. Most patients in our environ-
ment present late when the disease is already in
advanced stages. Recurrence rate following surgical
treatment was 33.3%. A high index of suspicion is
required in the management of chronic non-healing
ulcers that are recalcitrant to therapy and all suspected
lesions should be biopsed. Early recognition and aggres-
sive treatment of Marjolin’s ulcers and close follow-up
are urgently needed to improve outcomes in our envir-
onment. Health education is highly needed to discou-
rage patients with cutaneous ulcers from presenting late
to hospital when the disease is in its advanced stage.
Acknowledgements
The authors acknowledge all those who provided support in preparation of
this manuscript. Special thanks go to the staff members of Medical records
department of Bugando Medical Centre for their support during data
collection.
Author details
1Department of Surgery, Catholic University of Health and Allied Sciences-
Bugando, Mwanza, Tanzania.
2Department of Pathology, Catholic University
of Health and Allied Sciences-Bugando, Mwanza, Tanzania.
3Department of
Oncology, Catholic University of Health and Allied Sciences-Bugando,
Mwanza, Tanzania.
4Department of Surgery, Muhimbili University of Health
and Allied Sciences, Dar Es Salaam, Tanzania.
5Department of Plastic and
Reconstructive Surgery, Mulago Hospital Complex, Kampala, Uganda.
Authors’ contributions
PLC contributed in study design, literature search, data analysis, manuscript
writing, editing and submission of the manuscript. JBM, PR, ABC, GG and KJK
participated in study design, data analysis, manuscript writing & editing.
MDM participated in data analysis, manuscript writing & editing. NM and RS
participated in data analysis and manuscript writing. JMG supervised the
study and contributed in data analysis, manuscript writing & editing. All the
authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 28 December 2011 Accepted: 15 February 2012
Published: 15 February 2012
References
1. Sabin SR, Goldstein G, Rosenthal HG, Haynes KK: Aggressive squamous cell
carcinoma originating as a Marjolin’s ulcer. Dermatologic Surgery 2004,
30:229-30.
2. Duncan KO, Leffell DJ: Epithelial precancerous lesions. In Fitzpatrick’s
dermatology in general medicine.. 6 edition. Edited by: Freedberg IM, Eisen
AZ, Wolff K. New York: Mc Graw-Hill; 2003:719-36.
3. Marjolin NJ: Ulcère. Dictionnaire de medecine 1828, 21:31.
4. Treves N, Pack GT: The development of cancer in burn scars. Surg Gynecol
Obstet 1930, 51:749-782.
5. Da Costa JC: Carcinomatous changes in an area of chronic ulceration, or
Marjolin’s ulcer. Ann Surg 1903, 37:495-502.
6. Tan O, Atik B, Bekerecioglu M, Tercan M, Bayram I: Squamous carcinoma in
a pressure sore with a very short latency period. Eur J Plast Surg 2003,
26:360-2.
7. Er-Fan X, Li AO, Shi-ling W, Shao-Yu K, Guang-Xiu C: Burn scar carcinoma:
Case reports and review of the literature. Annals of the MBC 1992, 5:2.
8. Thio D, Clarkson JH, Misra A, Srivastava S: Malignant change after 18
months in a lower limb ulcer: Acute Marjolin’s ulcer revisited. British
Journal of Plastic Surgery 2003, 56:825-8.
9. Nthumba PM: Marjolin’s ulcers: theories, prognostic factors and their
peculiarities in spina bifida patients. World Journal of Surgical Oncology
2010, 8:108.
10. Ochenduszkiewicz U, Matkowski1 R, Szynglarewicz1 B, Kornafel J: Marjolin’s
ulcer: malignant neoplasm arising in scars. Rep Pract Oncol Radiother
2006, 11(3):135-138.
Chalya et al. World Journal of Surgical Oncology 2012, 10:38
http://www.wjso.com/content/10/1/38
Page 7 of 811. Dávalos BA, Cortés-Flores AO, Bandera-Delgado A: Malignant neoplasm in
burn scar: Marjolin’s ulcer: Report of two cases and review of the
literature. Cir Cir 2008, 76:329-31.
12. Nthumba PM: Marjolin’s ulcers in sub-Saharan Africa. World J Surg 2010,
34:2272-2277.
13. Chintamani M, Shankar M, Singhal V, Singh JP, Bansal A, Saxena S:
Squamous cell carcinoma developing in the scar of Fournier’s gangrene
Case report. BMC Cancer 2004, 274(1):16.
14. Calikapan GT, Akan M, Karaca M, Aköz T: Marjolin ulcer of the scalp:
intruder of a burn scar. J Craniofac Surg 2008, 19:1020-1025.
15. Ozek C, Celik N, Bilkay U, Akalin T, Erdem O, Cagdas A: Marjolin’s ulcer of
the scalp: Report of 5 cases and review of theliterature. J Burn Care
Rehabil 2001, 22:65-9.
16. Suhag V, Singh S, Nimbrian VK, Dimri K, Sharma N: Marjolin’s Ulcer
developing in electrical burns: A rare case report. Pakistan Journal of
Medical Science 2005, 21:375-6.
17. Daya M, Balakrishan T: Advanced Marjolin’s ulcer of the scalp in a 13-
year-old boy treated by excision and free tissue transfer: Case report
and review of literature. Indian J Plast Surg 2009, 42:106-.
18. Bozkurt M, Kapi E, Kuvat SV, Ozekinci S: Current concepts in the
management of Marjolin’s ulcers: outcomes from a standardized
treatment protocol in 16 cases. J Burn Care Res 2010, 31(5):776-80.
19. Fleming MD, Hunt JL, Purdue GF, Sandstad J: Marjolin’s ulcer: a review
and re-evaluation of a difficult problem. J Burn Care Rehabil 1990,
11(5):460-9.
20. Chlihi A, Bouchta A, Benbrahim A, Bahechar N, Boukind EH: The Marjolin’s
ulcer, destiny of an unstable scar: about 54 cases of burn’s sequalae.
Ann Chir Plast Esthet 2002, 47(4):291-297.
21. Aydogdu E, Yildirim S, Akoz T: Is surgery an effective and adequate
treatment in advanced matjolin’sulcer. Burns 2005, 31:421-31.
22. Hahn SB, Kim DJ, Jeon CH: Clinical study of Marjolin’s ulcer. Yonsei Med J
1990, 31(3):234-41.
23. Fishman RAJ, Parker MG: Malignancy and chronic wounds: Marjolin’s
Ulcer. J Burn Care Rehabil 1991, 12:218-23.
24. Hill BB, Sloan DA, Lee EY, McGrath PC, Kenady DE: Marjolin’s ulcer of the
foot caused by non-burn trauma. South Med J 1996, 89(7):707-10.
25. Neuman Z, Ben-Hur N, Shulman J: Trauma and skin cancer: implantation
of epidermal elements and possible cause. Plast Reconstr Surg 1963,
32:649-656.
26. Bostwick J, Pendergrast WJ, Vasconez LO: Marjolin’s ulcer: an
immunologically priviledged tumor? Plast Reconstr Surg 1975, 57:66-69.
27. Trent JT, Kirsner RS: Wounds and malignancy. Advances in Skin and Wound
Care 2003, 16:31-34.
28. Copcu E, Aktas A, Sismant N, Oztan Y: Thirty-one cases of Marjolin’s ulcer.
Clinical and Experimental Dermatology 2003, 28:138-41.
29. Lee SH, Shin MS, Kim HS: Somatic mutations of Fas (Apo-1/CD95) gene in
cutaneous cell carcinomas arising from a burn scar. Journal of
Investigative Dermatology 2000, 114(1):122-126.
30. Hayashi M, Tamura G, Kato N, Ansai S, Kondo S, Motoyama T: Genetic
analysis of cutaneous squamous cell carcinomas arising from different
areas. Patholology International 2003, 53(9):602-607.
31. Czarnecki D, Nicholson I, Tait B, Nash C: HLA DR4 is associated with the
development of multiple basal cell carcinomas and malignant
melanoma. Dermatolgica 1993, 187:16-18.
32. Harland DL, Robinson WA, Franklin WA: Deletion of the p53 gene in a
patient with aggressive burn scar carcinoma. J Trauma 1997, 42:104-107.
33. Gupta SK, Sandhir RK, Jaiswal AK, Kumar S: Marjolin’s ulcer of the scalp
invading calvarial bone, dura and brain. J Clin Neurosci 2005, 12:693-696.
34. Tutela RR Jr, Granick M, Benevenia J: Marjolin’s ulcer arising in pressure
ulcer. Adv Skin Wound Care 2004, 17:462-7.
35. Kowal-Vern A, Criswell BK: Burn scar neoplasms: a literature review and
statistical analysis. Burns 2005, 31:403-13.
36. Arons MS, Rodin AE, Lynch JB, Lewis SR, Blocker TG Jr: Scar tissue
carcinoma: II. An experimental study with special reference to burn scar
carcinoma. Ann Surg 1966, 163:445-60.
37. Lawrence EA, Moore TC: Carcinoma arising in the scars of thermal burns,
with special reference to the influence of the age at burn on the length
of the induction period. Surg Gynecol Obstet 1952, 95:579-90.
38. Novick M, Card DA, Hardy SB, Spira M: Bum scar carcinoma: a review and
analysis of 46 cases. J Trauma 1977, 17:809-17.
39. Celik E, ErogSlu S, KaracaogSlan N, Uzunismail A: Case report: Early arising
Marjolin’s ulcer in the scalp. Ann Burns Fire Disasters 2003, 16:217-21.
40. Malheiro E, Pinto A, Choupina M: Marjolin’s ulcer of the scalp: case report
and literature review. Ann Burns Fire Disasters 2001, 14:39-42.
41. Gamatsi E, McCulloch TA, Bailie FB, Srinivasan JR: Malignant melanoma in a
skin graft: burn scar neoplasm or a transferred melanoma. Br J Plast Surg
2000, 53:342-52.
42. Kontochristopoulos G, Kyriakis K, Symeonidou S, Katsiboulas V, Aroni K,
Panteleos D, Katsambas A: Squamous cell carcinoma in chronic trophic
ulcers of leprosy patients. J Eur Acad Dermatol Venerol 2000, 14:222-36.
43. Baldursson BT, Hedblad MA, Beitner H, Lindelöf B: Squamous cell
carcinoma complicating chronic venous leg ulceration: a study of the
histopathology, course and survival in 25 patients. Br J Dermatol 1999,
140:1148-52.
44. Eastman AL, Erdman WA, Lindberg GM, Hunt JL, Purdue GF, Fleming JB:
Sentinel lymph node biopsy identifies occult nodal metastases in
patients with Marjolin’ ulcer. J Burn Care Rehabil 2004, 25(3):241-5.
doi:10.1186/1477-7819-10-38
Cite this article as: Chalya et al.: Marjolin’s ulcers at a university
teaching hospital in Northwestern Tanzania: a retrospective review of
56 cases. World Journal of Surgical Oncology 2012 10:38.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Chalya et al. World Journal of Surgical Oncology 2012, 10:38
http://www.wjso.com/content/10/1/38
Page 8 of 8